Extracellularly activated nanocarriers: a new paradigm of tumor targeted drug delivery.
about
Nanotheranostics for personalized medicineHigh-Density Lipoproteins: Nature's Multifunctional NanoparticlesIntelligently targeted drug delivery and enhanced antitumor effect by gelatinase-responsive nanoparticlesAdvances in hormonal therapies for hormone naïve and castration-resistant prostate cancers with or without previous chemotherapyExtracellularly activatable nanocarriers for drug delivery to tumors.The in vivo performance of plasmonic nanobubbles as cell theranostic agents in zebrafish hosting prostate cancer xenograftsOptically guided controlled release from liposomes with tunable plasmonic nanobubbles.Plasmonic nanobubbles as tunable cellular probes for cancer theranosticsBromelain surface modification increases the diffusion of silica nanoparticles in the tumor extracellular matrixMagnetic colloidal supraparticles: design, fabrication and biomedical applications.Encapsulation of acetylshikonin by polyamidoamine dendrimers for preparing prominent nanoparticles.Oil phase evaporation-induced self-assembly of hydrophobic nanoparticles into spherical clusters with controlled surface chemistry in an oil-in-water dispersion and comparison of behaviors of individual and clustered iron oxide nanoparticlesTargeting gold nanocages to cancer cells for photothermal destruction and drug deliveryLipid-based nanoparticles as pharmaceutical drug carriers: from concepts to clinicRationally designed logic integration of regulatory signals in mammalian cells.A tumor-acidity-activated charge-conversional nanogel as an intelligent vehicle for promoted tumoral-cell uptake and drug delivery.Intratumoral drug delivery with nanoparticulate carriers.Drug resistance and cellular adaptation to tumor acidic pH microenvironmentA Multi-Functional Tumor Theranostic Nanoplatform for MRI Guided Photothermal-Chemotherapy.Nanotechnology-based approaches in anticancer researchRedox-sensitive nanoparticles from amphiphilic cholesterol-based block copolymers for enhanced tumor intracellular release of doxorubicin.Stimuli-responsive nanoparticles for targeting the tumor microenvironment.In vitro and in vivo evaluation of docetaxel-loaded stearic acid-modified Bletilla striata polysaccharide copolymer micelles.Advanced targeted nanomedicineCurb challenges of the "Trojan Horse" approach: smart strategies in achieving effective yet safe cell-penetrating peptide-based drug delivery.Polydopamine-based surface modification for the development of peritumorally activatable nanoparticlesAssessment of the evolution of cancer treatment therapies"Clickable" polymer nanoparticles: a modular scaffold for surface functionalization.Synthetic high-density lipoproteins for delivery of 10-hydroxycamptothecin.Stimuli-Responsive Programmed Specific Targeting in Nanomedicine.Reversibly extracellular pH controlled cellular uptake and photothermal therapy by PEGylated mixed-charge gold nanostars.Epithelial cell adhesion molecule aptamer functionalized PLGA-lecithin-curcumin-PEG nanoparticles for targeted drug delivery to human colorectal adenocarcinoma cells.Targeting liposomes toward novel pediatric anticancer therapeutics.Nanostructured hyaluronic acid-based materials for active delivery to cancer.Molecular imaging and targeted therapies.Synthesis, functionalization, and biomedical applications of multifunctional magnetic nanoparticles.Stimulus-responsive macromolecules and nanoparticles for cancer drug delivery.Nanoparticles for cell labeling.Receptor-targeted nanocarriers for therapeutic delivery to cancer.The rise and rise of stealth nanocarriers for cancer therapy: passive versus active targeting.
P2860
Q26851449-F2168C7A-8210-4B00-841F-E62BBC2A1D3DQ28077290-A42A3B71-EDD3-48E0-A7CE-6829D92F322EQ28534995-F938FC2E-FF30-4E85-A879-24D4615EE3D8Q28829239-D7490698-36B2-4CAB-8D1E-0E788ACC6982Q30401826-DA3F5775-B584-4617-BEAD-283CEB9B6939Q30473892-68DD05C1-C20B-4B85-B259-181CD3CFADC9Q30475318-DFBED06A-2708-4329-808C-37A8FC59D3F5Q30476207-236F1E08-5A45-4660-BCFA-173A909DEED2Q30596466-D97B3C02-1462-466B-ACB1-9420E2676767Q30664539-62521DD3-0BE2-42B1-8F10-B535EC600A47Q30739130-A870A380-09C0-4945-9C0A-BAA48F1203DEQ33758687-9F33DA82-8906-4A4F-8213-AFF3351634A0Q33805083-6C9FC0AA-3DD2-407B-9D12-2456BF4A40A6Q33911056-C53F844F-BDD5-4CB2-8899-62B623172E78Q34108156-DDE7B1DB-5176-4185-80CB-943818F85B00Q34110105-93641DCE-759D-4E35-9F0D-84A1DACC9072Q35091415-D538014C-199E-47DD-81F8-0CDF91190EEBQ35592647-8D43FB4A-AD42-407B-9D65-9A35CA669376Q35960057-8925F8C9-9BC4-42A5-9821-FE8B1F54E1BCQ36168983-039EDCFF-CB08-47E9-8F1B-94BF58E2A800Q36236817-9DBAEB99-41BC-40C4-B0F0-1D0B8CE63476Q36307519-B404A07A-EB12-46FC-A83A-F7BF5061ED3FQ36320160-35CED5DC-5CC9-4F30-9709-08591951133CQ36388931-06E8C187-330B-4AF6-BEC7-4830F94782D2Q36854231-A5645C9A-C155-4F18-8E87-1ED0AC79FED6Q36979875-D4A90203-178B-4AA2-94C3-E33BD930AA3AQ37137408-6635D703-918E-40A2-B347-294F8C588AC6Q37389368-163A453E-982D-46A0-9DAC-96EFE4F8CEC7Q37446423-607DBB62-F951-4054-8194-698C49D15D6BQ37575697-ECCEE601-91A1-4738-9A9C-644E783FD5D0Q37581385-CEEABCD9-EB59-4CE7-9BF4-6D8F45F5B807Q37607750-63EB34D6-A97E-440E-B688-E4EBE100EC9CQ37684734-4814E23E-E7DB-41E9-86FE-BF2CD81B31B1Q37724371-EBA44DDA-5A89-4412-9F10-7485A670EADFQ37732704-8B9CD173-D662-4643-800E-8D1E6603E4C0Q37754141-068DDFE3-F870-4EF8-9F35-CEB327B610FEQ37775972-F0951DAA-456F-4E31-8D23-02DC866E9315Q37799541-7D082325-9B68-4B97-AF4E-C34F565A9874Q37804383-9DB1F492-AB08-4494-89CB-485ACCB48E74Q37815479-7BE86F8B-C1CF-4A68-886A-5D718A4C319A
P2860
Extracellularly activated nanocarriers: a new paradigm of tumor targeted drug delivery.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Extracellularly activated nanocarriers: a new paradigm of tumor targeted drug delivery.
@en
Extracellularly activated nanocarriers: a new paradigm of tumor targeted drug delivery.
@nl
type
label
Extracellularly activated nanocarriers: a new paradigm of tumor targeted drug delivery.
@en
Extracellularly activated nanocarriers: a new paradigm of tumor targeted drug delivery.
@nl
prefLabel
Extracellularly activated nanocarriers: a new paradigm of tumor targeted drug delivery.
@en
Extracellularly activated nanocarriers: a new paradigm of tumor targeted drug delivery.
@nl
P2860
P356
P1476
Extracellularly activated nanocarriers: a new paradigm of tumor targeted drug delivery.
@en
P2093
Emily Gullotti
P2860
P304
P356
10.1021/MP900090Z
P407
P577
2009-07-01T00:00:00Z